CAPOGROSSO, Roberta Francesca
 Distribuzione geografica
Continente #
NA - Nord America 814
EU - Europa 121
AS - Asia 78
OC - Oceania 1
Totale 1.014
Nazione #
US - Stati Uniti d'America 813
CN - Cina 56
IT - Italia 56
SE - Svezia 31
SG - Singapore 12
FI - Finlandia 9
GB - Regno Unito 7
DE - Germania 4
VN - Vietnam 4
BE - Belgio 3
FR - Francia 3
IN - India 3
NL - Olanda 3
UA - Ucraina 3
IE - Irlanda 2
JP - Giappone 2
AU - Australia 1
CA - Canada 1
HK - Hong Kong 1
Totale 1.014
Città #
Fairfield 132
Woodbridge 94
Houston 81
Chandler 79
Ashburn 74
Cambridge 55
Seattle 48
Wilmington 39
Nyköping 29
Ann Arbor 28
Bari 26
New York 18
Beijing 17
Roxbury 9
Inglewood 8
Lawrence 7
Des Moines 6
Jacksonville 6
Shenyang 6
Nanchang 5
Nanjing 5
Redwood City 5
Sennori 5
Singapore 5
Brooklyn 4
Dong Ket 4
Los Angeles 4
Brussels 3
Helsinki 3
London 3
San Diego 3
San Mateo 3
Tianjin 3
Boardman 2
Dearborn 2
Dublin 2
Guangzhou 2
Hebei 2
Jinan 2
Leawood 2
Monmouth Junction 2
Princeton 2
Pune 2
Santa Clara 2
Seveso 2
Changsha 1
Chicago 1
Fort Erie 1
Haikou 1
Hefei 1
Indiana 1
Jiaxing 1
Jinhua 1
Las Vegas 1
Liverpool 1
Munich 1
Norma 1
Nürnberg 1
Rome 1
San Francisco 1
Sassari 1
Shanghai 1
Shaoxing 1
Sydney 1
Torino 1
Tsuen Wan 1
Valenzano 1
Washington 1
Wuhan 1
Totale 865
Nome #
Effects of Nandrolone in the counteraction of skeletal muscle atrophy in a mouse model of muscle disuse: molecular biology and functional evaluation 137
Assessment of resveratrol, apocynin and taurine on mechanical-metabolic uncoupling and oxidative stress in a mouse model of Duchenne muscular dystrophy: a comparison with the gold standard, α-methyl prednisolone. 130
Contractile efficiency of dystrophic mdx mouse muscle: In vivo and ex vivo assessment of adaptation to exercise of functional end points 124
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy. 111
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy 111
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 98
null 92
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 91
null 68
null 61
GLPG0492, a novel selective androgen receptor modulator, improves muscle performance in the exercised-mdx mouse model of muscular dystrophy 28
Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase. 20
Gene expression in mdx mouse muscle in relation to age and exercise: aberrant mechanical-metabolic coupling and implications for pre-clinical studies in duchenne muscular dystrophy 19
Totale 1.090
Categoria #
all - tutte 3.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020240 0 17 11 33 26 19 24 33 29 20 19 9
2020/2021250 15 14 9 38 20 11 17 10 13 58 33 12
2021/202287 4 4 2 1 0 11 4 2 9 12 15 23
2022/2023166 9 24 11 19 19 24 1 19 28 1 9 2
2023/202472 5 10 2 4 7 22 1 10 0 5 1 5
2024/202523 20 3 0 0 0 0 0 0 0 0 0 0
Totale 1.090